Search - tctmd.com

Displaying 941 - 960 of 1481

Sort: Relevancy | Date

News Industry News

OrbusNeich’s COMBO™ Dual Therapy Stent Featured in TCT 2013 Satellite Symposium

October 31, 2013

Presentation TCT 2013

Neoatherosclerosis: OCT and NIRS Findings and Their Clinical Implications

Presenter: Ziad Ali

October 31, 2013

Presentation TCT 2013

Identifying and Managing Embolic-Prone Lesions: RF-IVUS, OCT, and NIRS

Presenter: Emmanouil Brilakis

October 31, 2013

Presentation TCT 2013

Geographic Miss: VH-IVUS, OCT and NIRS Findings and Their Clinical Importance

Presenter: Hiram Grando Bezerra

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloon Mechanisms of Action: Insights From Angiography, FFR and OCT

Presenter: Pierfrancesco Agostoni

October 31, 2013

Presentation TCT 2013

Case 3: Acute Myocardial Infarction: Is There a Role for Routine IVUS/OCT?

Presenter: Bernhard Witzenbichler

October 31, 2013

Presentation TCT 2013

Case #4: OCT Case

Presenter: Kevin Croce

October 31, 2013

Presentation TCT 2013

Can Detection of Stable Coronary Plaque Composition by OCT, RF-IVUS, or NIR Spectroscopy Replace or Supplement Physiologic Lesion Assessment?

Presenter: Akiko Maehara

October 31, 2013

News Industry News

Study Examines the Impact of Insulin Treatment Status in Diabetic Patients with Multivessel Coronary Artery Disease

October 31, 2013

News Conference News TCT 2013

Second-Generation TAVR Device Overcomes Issues of Current Valves

October 31, 2013

News Industry News

Second Generation Transcatheter Aortic Valve Shown to Successfully Address Complications of TAVR

October 31, 2013

News Industry News

Removing Blood Clots during PCI Does Not Improve Outcomes Compared To Standard Angioplasty in Patients with Non-St-Elevation Myocardial Infarction

October 31, 2013

News Industry News

New Study Finds Patients who are Event-Free Following PCI at One Year May Not Need Prolonged Dual Antiplatelet Therapy

October 31, 2013

News Industry News

New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated With a Second Generation Drug-Eluting Stent

October 31, 2013

News Industry News

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

October 31, 2013

News Industry News

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent

October 31, 2013

Presentation TCT 2013

Vulnerable Plaque Diagnosis by OCT (with Case Vignettes)

Presenter: Ik-Kyung Jang

October 30, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Regulatory Hurdles Pose Challenges for Device Approvals in US, Europe

October 30, 2013

Presentation TCT 2013

Micro OCT: The Future of Invasive Imaging?

Presenter: Guillermo Tearney

October 30, 2013

Advertisement

OrbusNeich’s COMBO™ Dual Therapy Stent Featured in TCT 2013 Satellite Symposium

Neoatherosclerosis: OCT and NIRS Findings and Their Clinical Implications

Identifying and Managing Embolic-Prone Lesions: RF-IVUS, OCT, and NIRS

Geographic Miss: VH-IVUS, OCT and NIRS Findings and Their Clinical Importance

Drug-Coated Balloon Mechanisms of Action: Insights From Angiography, FFR and OCT

Case 3: Acute Myocardial Infarction: Is There a Role for Routine IVUS/OCT?

Case #4: OCT Case

Can Detection of Stable Coronary Plaque Composition by OCT, RF-IVUS, or NIR Spectroscopy Replace or Supplement Physiologic Lesion Assessment?

Study Examines the Impact of Insulin Treatment Status in Diabetic Patients with Multivessel Coronary Artery Disease

Second-Generation TAVR Device Overcomes Issues of Current Valves

Second Generation Transcatheter Aortic Valve Shown to Successfully Address Complications of TAVR

Removing Blood Clots during PCI Does Not Improve Outcomes Compared To Standard Angioplasty in Patients with Non-St-Elevation Myocardial Infarction

New Study Finds Patients who are Event-Free Following PCI at One Year May Not Need Prolonged Dual Antiplatelet Therapy

New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated With a Second Generation Drug-Eluting Stent

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent

Vulnerable Plaque Diagnosis by OCT (with Case Vignettes)

Two Trials to Assess TAVR in Moderate-Risk Patients

Regulatory Hurdles Pose Challenges for Device Approvals in US, Europe

Micro OCT: The Future of Invasive Imaging?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content